Geller Matthew
Director at BIOSPECIFICS TECHNOLOGIES CORP
- Sold, on record
- $725k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 7, 2011
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOSPECIFICS TECHNOLOGIES CORPDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualMay 23 2011
Sold 12,300 shares at $24.01 ($295k)
Geller Matthew, Director
Sold 41% of holdings ($720k position)17,700 shares leftFirst sale on recordFiling
- 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualMay 24 +1 day
Sold 7,700 shares at $24.08 ($185k)
Geller Matthew, Director
Sold 43.5% of holdings ($426k position)10,000 shares leftFiling
- 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualJun 7 +14 days
Sold 10,000 shares at $24.40 ($244k)
Geller Matthew, Director
Sold 100% of holdings ($244k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2011 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 10,000 | $244k | 100.0% | Unusual | SEC |
| May 24, 2011 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 7,700 | $185k | 43.5% | Unusual | SEC |
| May 23, 2011 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 12,300 | $295k | 41.0% | Unusual | SEC |